The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Economic Burden of Obesity: A Systematic Literature Review
Open accessAbstract
Background: The rising prevalence of obesity represents an important public health issue. An assessment of its costs may be useful in providing recommendations for policy and decision makers. This systematic review aimed to assess the economic burden of obesity and to identify, measure and describe the different obesity-related diseases included in the selected studies. Methods: A systematic literature search of studies in the English language was carried out in Medline (PubMed) and Web of Science databases to select cost-of-illness studies calculating the cost of obesity in a study population aged ≥18 years with obesity, as defined by a body mass index of ≥30 kg/m², for the whole selected country. The time frame for the analysis was January 2011 to September 2016. Results: The included twenty three studies reported a substantial economic burden of obesity in both developed and developing countries. There was considerable heterogeneity in methodological approaches, target populations, study time frames, and perspectives. This prevents an informative comparison between most of the studies. Specifically, there was great variety in the included obesity-related diseases and complications among the studies. Conclusions: There is an urgent need for public health measures to prevent obesity in order to save societal resources. Moreover, international consensus is required on standardized methods to calculate the cost of obesity to improve homogeneity and comparability. This aspect should also be considered when including obesity-related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
(2000) · PubMed · Cited by 13,173
Child abuse: Adolescent records vs. adult recall
Femina, D. D., Yeager, C. A., & Lewis, D. O. (1990) · Child Abuse & Neglect · doi:10.1016/0145-2134(90)90033-p · Cited by 8,820
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Finkelstein, E. A., Trogdon, J. G., Cohen, J. W., & Dietz, W. (2009) · Health Affairs · doi:10.1377/hlthaff.28.5.w822 · Cited by 2,957
Estimating the true global burden of mental illness
Vigo, D., Thornicroft, G., & Atun, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00505-2 · Cited by 2,494
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493
The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action
Di Cesare, M., Sorić, M., Bovet, P., Miranda, J. J., Bhutta, Z., Stevens, G. A., Laxmaiah, A., Kengne, A.-P., & Bentham, J. (2019) · BMC Medicine · doi:10.1186/s12916-019-1449-8 · Cited by 1,090
The Heavy Burden of Obesity: The Economics of Prevention
OECD (2019) · OECD Health Policy Studies · doi:10.1787/67450d67-en · Cited by 1,090
Economic impacts of overweight and obesity: current and future estimates for 161 countries
Okunogbe, A., Nugent, R., Spencer, G., Powis, J., Ralston, J., & Wilding, J. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009773 · Cited by 724
Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
Sarma, S., Sockalingam, S., & Dash, S. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14290 · Cited by 435
Current pharmacotherapy for obesity
Srivastava, G., & Apovian, C. M. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.122 · Cited by 397
Anekwe, C. V., Jarrell, A. R., Townsend, M. J., Gaudier, G. I., Hiserodt, J. M., & Stanford, F. C. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00398-7 · Cited by 372
Why primary obesity is a disease?
De Lorenzo, A., Gratteri, S., Gualtieri, P., Cammarano, A., Bertucci, P., & Di Renzo, L. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1919-y · Cited by 370
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 370
Sociodemographic Factors Influencing the Use of eHealth in People with Chronic Diseases
Reiners, F., Sturm, J., Bouw, L. J. W., & Wouters, E. J. M. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16040645 · Cited by 257
Using genetics to understand the causal influence of higher BMI on depression
Tyrrell, J., Mulugeta, A., Wood, A. R., Zhou, A., Beaumont, R. N., Tuke, M. A., Jones, S. E., Ruth, K. S., Yaghootkar, H., Sharp, S., et al. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy223 · Cited by 256
Jayedi, A., Soltani, S., Motlagh, S. Z.-T., Emadi, A., Shahinfar, H., Moosavi, H., & Shab-Bidar, S. (2022) · BMJ · doi:10.1136/bmj-2021-067516 · Cited by 253
White adipose tissue dysfunction in obesity and aging
Reyes-Farias, M., Fos-Domenech, J., Serra, D., Herrero, L., & Sánchez-Infantes, D. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114723 · Cited by 250
Gaps to bridge: Misalignment between perception, reality and actions in obesity
Caterson, I. D., Alfadda, A. A., Auerbach, P., Coutinho, W., Cuevas, A., Dicker, D., Hughes, C., Iwabu, M., Kang, J., Nawar, R., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13752 · Cited by 210
A review of current guidelines for the treatment of obesity
(2022) · The American Journal of Managed Care · doi:10.37765/ajmc.2022.89292 · Cited by 207
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
Kosiborod, M. N., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Khalid, U., Kushner, R., Rubino, D. M., Zeuthen, N., & Verma, S. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14890 · Cited by 127
“It imposes substantial economic burdens on patients, health care systems and wider society through direct health care expenditure and indirect costs, such as lost productivity.(3) As obesity can lead to increased multimorbidity and reduced life expectancy,(4-7) its increasing prevalence is an urgent public health conc…”
BackgroundBenefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani, A. A., & Morton, J. (2022) · Obesity · doi:10.1002/oby.23371 · Cited by 125
Obesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective
Prokopidis, K., Cervo, M. M., Gandham, A., & Scott, D. (2020) · Nutrients · doi:10.3390/nu12082285 · Cited by 99
Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists
Barrett, T. S., Hafermann, J. O., Richards, S., LeJeune, K., & Eid, G. M. (2025) · JAMA Surgery · doi:10.1001/jamasurg.2025.3590 · Cited by 87
Morgan-Bathke, M., Raynor, H. A., Baxter, S. D., Halliday, T. M., Lynch, A., Malik, N., Garay, J. L., & Rozga, M. (2023) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.11.014 · Cited by 85
Tobore, T. O. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112560 · Cited by 73
Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action
Mohajer, N., Du, C. Y., Checkcinco, C., & Blumberg, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.780888 · Cited by 72
“The CDC reported the national obesity-related cost to be $147 billion in 2008, however, more recent data from 2014 estimates the cost of obesity and its comorbidities to be closer to $2 trillion dollars (10, 11).”
BackgroundPersistence of newer anti-obesity medications in a real-world setting
Ganguly, R., Tian, Y., Kong, S. X., Hersloev, M., Hobbs, T., Smolarz, B. G., Ramasamy, A., Haase, C. L., & Weng, W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.017 · Cited by 68
Ahmad, N. N., Robinson, S., Kennedy‐Martin, T., Poon, J. L., & Kan, H. (2021) · Obesity Reviews · doi:10.1111/obr.13326 · Cited by 69
He, S., Wang, J., Zhang, J., & Xu, J. (2021) · Obesity · doi:10.1002/oby.23023 · Cited by 60
Haase, C. L., Eriksen, K. T., Lopes, S., Satylganova, A., Schnecke, V., & McEwan, P. (2021) · Obesity Science & Practice · doi:10.1002/osp4.474 · Cited by 57
“Although a sizable proportion of obesity‐related costs and resource use are known to be contributed by complications of the disease,(34,35) there is considerable variation in which conditions are included in overall cost estimation for obesity.(36) Therefore, as well as demonstrating the cost benefits to be gained by…”
BackgroundShort-term weight loss reverses obesity-induced microvascular endothelial dysfunction
Csipo, T., Fulop, G. A., Lipecz, A., Tarantini, S., Kiss, T., Balasubramanian, P., Csiszar, A., Ungvari, Z., & Yabluchanskiy, A. (2018) · GeroScience · doi:10.1007/s11357-018-0028-9 · Cited by 50
Present and Future of Digital Health in Diabetes and Metabolic Disease
Rhee, S. Y., Kim, C., Shin, D. W., & Steinhubl, S. R. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0088 · Cited by 47
Strategies to reduce attrition in weight loss interventions: A systematic review and meta‐analysis
Pirotta, S., Joham, A., Hochberg, L., Moran, L., Lim, S., Hindle, A., & Brennan, L. (2019) · Obesity Reviews · doi:10.1111/obr.12914 · Cited by 45
Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Conceição-Furber, E., Coskun, T., Sloop, K. W., & Samms, R. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.868037 · Cited by 48
Cattivelli, R., Castelnuovo, G., Musetti, A., Varallo, G., Spatola, C. A. M., Riboni, F. V., Usubini, A. G., Tosolin, F., Manzoni, G. M., Capodaglio, P., et al. (2018) · Trials · doi:10.1186/s13063-018-2968-x · Cited by 41
“Interventions developed in this way, including dietary education protocols, physical rehabilitation and exercise programs, and nutritional, endocrinal, psychological, surgical, and pharmacological treatments, are generally effective in the short term, despite many of them being characterized by high costs and long per…”
BackgroundBoysen, O., Boysen-Urban, K., Bradford, H., & Balié, J. (2019) · World Development · doi:10.1016/j.worlddev.2019.03.006 · Cited by 37
Kang, M.-C., Ding, Y., Kim, H.-S., Jeon, Y.-J., & Lee, S.-H. (2019) · Marine Drugs · doi:10.3390/md17010044 · Cited by 37
Lei, L., Huang, J., Zhang, L., Hong, Y., Hui, S., & Yang, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.935234 · Cited by 35
Kohl, J., Brame, J., Centner, C., Wurst, R., Fuchs, R., Sehlbrede, M., Tinsel, I., Maiwald, P., Fichtner, U. A., Armbruster, C., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/43426 · Cited by 29
Maalin, N., Mohamed, S., Kramer, R. S. S., Cornelissen, P. L., Martin, D., & Tovée, M. J. (2021) · Behavior Research Methods · doi:10.3758/s13428-020-01494-1 · Cited by 25
Karagun, B., & Baklaci, N. (2024) · Medicine · doi:10.1097/md.0000000000039542 · Cited by 24
“[4] The primary contributors to obesity are excessive and unhealthy eating habits, coupled with physical inactivity.”
BackgroundGómez-de-Regil, L., Avila-Nava, A., Gutierrez-Solis, A. L., & Lugo, R. (2020) · Journal of Healthcare Engineering · doi:10.1155/2020/9317179 · Cited by 20
“-e epidemic of overweight and obesity is expanding rapidly and to younger ages; thus, it has become a major challenge to healthcare systems due to their high economic and psychosocial burden [3, 4, 36, 37].”
BackgroundLOPEZ, P., RADAELLI, R., TAAFFE, D. R., GALVÃO, D. A., NEWTON, R. U., NONEMACHER, E. R., WENDT, V. M., BASSANESI, R. N., TURELLA, D. J. P., & RECH, A. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002984 · Cited by 21
Targeting skeletal muscle mitochondrial health in obesity
Pileggi, C. A., Hooks, B. G., McPherson, R., Dent, R. R. M., & Harper, M.-E. (2022) · Clinical Science · doi:10.1042/cs20210506 · Cited by 21
Alshehri, A., AlFaris, N., Al Qahtani, A. M., Shams, M., & Yahia, M. (2023) · Clinical Obesity · doi:10.1111/cob.12594 · Cited by 11
“pandemic carries a large negative economic impacty due to its high healthcare cost.(3) Obesity is a chronic, progressive, relapsing disease associated”
BackgroundWatkins, S., Toliver, J. C., Kim, N., Whitmire, S., & Garvey, W. T. (2022) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2022.22116 · Cited by 10
Obesity, cardiovascular and cerebrovascular disease: the role of GLP-1 receptor agonists
Tirandi, A., Montecucco, F., Carbone, F., & Liberale, L. (2024) · Polish Archives of Internal Medicine · doi:10.20452/pamw.16658 · Cited by 8
Juul‐Hindsgaul, N., Alalwani, Z., Boylan, A., Hartmann‐Boyce, J., & Nunan, D. (2024) · Clinical Obesity · doi:10.1111/cob.12631 · Cited by 6
Castelão-Baptista, J. P., Valente, S. A., Canário, S., Oppolzer, D., Barros, A., Venâncio, C., Martins, T., Antunes, L., Sardão, V. A., Rosa, E., et al. (2023) · Nutrients · doi:10.3390/nu15040924 · Cited by 5
Public Health Department, S. O. M. A. H. S., Kurniawan, F., Prabandari, Y. S., Faculty of Medicine, P. H., Ismail, D., Faculty of Medicine, P. H., Dewi, F. T., & Faculty of Medicine, P. H. (2022) · Malaysian Journal of Nutrition · doi:10.31246/mjn-2020-0101 · Cited by 2
Metadata
- Authors
- Tremmel, M., Gerdtham, U.-G., Nilsson, P., & Saha, S.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2017-04-19
- Volume
- 14
- Issue
- 4
- Pages
- 435
- ISSN
- 1660-4601 (ISSN-L)
- OpenAlex
- W2605606367
- Cited by
- 1,154
- References
- 73
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.